Clinical Trial Update: The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

View source ↗

Summary

An update on a clinical trial evaluating the efficacy of IUrisure for detecting recurrent urothelial carcinoma; the current status of the trial is not disclosed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• IUrisure

Snippet

Sponsor: Wuhan Ammunition Life-tech Co., Ltd | Conditions: Urothelial Carcinoma | Status: UNKNOWN